[1]
|
Hoffman, G.S., Kerr, G.S., Leavitt, R.Y., et al. (1992) Wegener Granulomatosis: An Analysis of 158 Patients. Annals of Internal Medicine, 116, 488-498. https://doi.org/10.7326/0003-4819-116-6-488
|
[2]
|
Jennette, J.C. (2011) Nomenclature and Classification of Vasculitis: Lessons Learned from Granulomatosis with Polyangiitis (Wegener’s Granulomatosis). Clinical and Experimental Immunology, 164, 7-10. https://doi.org/10.1111/j.1365-2249.2011.04357.x
|
[3]
|
Ursea, R., De Castro, D., Bowen, T.J. and Chan, C.C. (2015) The Role of Conjunctival Biopsy in the Diagnosis of Granulomatosis with Polyangiitis. The Journal of Ophthalmic Inflammation and Infection, 5, Article No. 1. https://doi.org/10.1186/s12348-014-0033-9
|
[4]
|
Rothschild, P.R., Pagnoux, C., Seror, R., et al. (2013) Ophthalmologic Manifestations of Systemic Necrotizing Vasculitides at Diagnosis: A Retrospective Study of 1286 Patients and Review of the Literature. Seminars in Arthritis and Rheumatism, 42, 507-514. https://doi.org/10.1016/j.semarthrit.2012.08.003
|
[5]
|
Kubaisi, B., Samra, A.K. and Foster, C.S. (2016) Granulomatosis with Polyangiitis (Wegener’s Disease): An Updated Review of Ocular Disease Manifestations. Intractable & Rare Diseases Research, 5, 61-69. https://doi.org/10.5582/irdr.2016.01014
|
[6]
|
Puechal, X. (2007) Antineutrophil Cytoplasmic Antibody-Associated Vasculitides. Joint Bone Spine, 74, 427-435. https://doi.org/10.1016/j.jbspin.2007.02.001
|
[7]
|
Gheita, T.A. and Abd El Latif, E.M. (2019) Relationship of Ocular Presentation in Granulomatosis with Polyangiitis to Autoantibodies and Disease Activity. Zeitschrift für Rheumatologie, 78, 281-286. https://doi.org/10.1007/s00393-018-0495-5
|
[8]
|
Generali, E., Cantarini, L. and Selmi, C. (2015) Ocular Involvement in Systemic Autoimmune Diseases. Clinical Reviews in Allergy & Immunology, 49, 263-270. https://doi.org/10.1007/s12016-015-8518-3
|
[9]
|
Rosenbaum, J.T. (2017) The Eye and Rheumatic Diseases. In: Firestein, G.S., Budd, R.C., Gabriel, S.E., McInnes, I.B. and O’Dell, J.R., Eds., Kelley and Firestein’s Textbook of Rheumatology, Elsevier, Philadelphia, 645-653, Chapter 44.
|
[10]
|
Jiang, B., Zhao, Y.Y. and Wei, S.H. (2013) Granulomatosis with Polyangiitis: The Relationship between Ocular and Nasal Disease. Ocular Immunology and Inflammation, 21, 115-118. https://doi.org/10.3109/09273948.2012.747618
|
[11]
|
Holle, J.U., Voigt, C., Both, M., et al. (2013) Orbital Masses in Granulomatosis with Polyangiitis Are Associated with a Refractory Course and a High Burden of Local Damage. Rheumatology (Oxford), 52, 875-882. https://doi.org/10.1093/rheumatology/kes382
|
[12]
|
Tan, L.T., Davagnanam, I., Isa, H., et al. (2014) Clinical and Imaging Features Predictive of Orbital Granulomatosis with Polyangiitis and the Risk of Systemic Involvement. Ophthalmology, 121, 1304-1309. https://doi.org/10.1016/j.ophtha.2013.12.003
|
[13]
|
Boukes, R.J. and de Vries-Knoppert, W.A. (1985) Lacrimal Gland Enlargement as One of the Ocular Manifestations of Wegener’s Granulomatosis. Documenta Ophthalmologica, 59, 21-26. https://doi.org/10.1007/BF00162005
|
[14]
|
Kiseleva, T.N., Grusha, I.O., Polunina, A.A., et al. (2009) Involvement of Lacrimal Organs in Wegener’s Granulomatosis. Vestnik oftalmologii, 125, 33-36.
|
[15]
|
Howe, L., D’Cruz, D., Chopdar, A., et al. (1995) Anterior Ischaemic Optic Neuropathy in Wegener’s Granulomatosis. European Journal of Ophthalmology, 5, 277-279. https://doi.org/10.1177/112067219500500415
|
[16]
|
Jennette, J.C., Falk, R.J., Bacon, P.A., et al. (2013) 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis & Rheumatology, 65, 1-11. https://doi.org/10.1002/art.37715
|
[17]
|
de Souza, F.H., Radu Halpern, A.S., Valente Barbas, C.S., et al. (2010) Wegener’s Granulomatosis: Experience from a Brazilian Tertiary Center. Clinical Rheumatology, 29, 855-860. https://doi.org/10.1007/s10067-010-1408-4
|
[18]
|
Reinhold-Keller, E., Beuge, N., Latza, U., et al. (2000) An Interdisciplinary Approach to the Care of Patients with Wegener’s Granulomatosis: Long-Term Outcome in 155 Patients. Arthritis & Rheumatology, 43, 1021-1032. https://doi.org/10.1002/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J
|
[19]
|
Matteson, E.L., Gold, K.N. and Bloch, D.A. (1996) Long-Term Survival of Patients with Wegener’s Granulomatosis from the American College of Rheumatology Wegener’s Granulomatosis Classification Criteria Cohort. The American Journal of Medicine, 101, 129-134. https://doi.org/10.1016/S0002-9343(96)80066-0
|
[20]
|
Pakrou, N., Selva, D. and Leibovitch, I. (2006) Wegener’s Granulomatosis: Ophthalmic Manifestations and Management. Seminars in Arthritis and Rheumatism, 35, 284-292. https://doi.org/10.1016/j.semarthrit.2005.12.003
|
[21]
|
Stone, J.H. and Wegener’s Granulomatosis Etanercept Trial Research Group (2003) Limited versus Severe Wegener’s Granulomatosis: Baseline Data on Patients in the Wegener’s Granulomatosis Etanercept Trial. Arthritis & Rheumatology, 48, 2299-2309. https://doi.org/10.1002/art.11075
|
[22]
|
Aldasoro-Cáceres, V., Aldasoro-Cáceres, I., Pérez-Moreiras, J.V., et al. (2014) C-ANCA Positive Necrotizing Scleritis and Multiple Sclerosis Compatible with Ocular Wegener: Treatment with Rituximab. Archivos de la Sociedad Española de Oftalmología, 89, 31-34. https://doi.org/10.1016/j.oftal.2012.06.020
|
[23]
|
Solans-Laqué, R., Fraile, G., Rodriguez-Carballeira, M., et al. (2017) Clinical Characteristics and Outcome of Spanish Patients with ANCA Associated Vasculitides: Impact of the Vasculitis Type, ANCA Specificity, and Treatment on Mortality and Morbidity. Medicine (Baltimore), 96, e6083. https://doi.org/10.1097/MD.0000000000006083
|
[24]
|
Torres, R.M., Herreras, J.M., Becerra, E., et al. (2004) Ocular Presentation in Wegener Granulomatosis. Archivos de la Sociedad Española de Oftalmología, 79, 135-138. https://doi.org/10.4321/S0365-66912004000300008
|
[25]
|
Hinojosa-Azaola, A., García-Castro, A., Juárez-Flores, A., et al. (2019) Clinical Significance of Ocular Manifestations in Granulomatosis with Polyangiitis: Association with Sinonasal Involvement and Damage. Rheumatology International, 39, 489-495. https://doi.org/10.1007/s00296-019-04242-7
|
[26]
|
Akpek, E.K., Uy, H.S., Christen, W., et al. (1999) Severity of Episcleritis and Systemic Disease Association. Ophthalmology, 106, 729-731. https://doi.org/10.1016/S0161-6420(99)90157-4
|
[27]
|
Sainz de la Maza, M., Foster, C.S. and Jabbur, N.S. (1995) Scleritis Associated with Systemic Vasculitic Diseases. Ophthalmology, 102, 687-692. https://doi.org/10.1016/S0161-6420(95)30970-0
|
[28]
|
Chung, S. and Monach, P.A. (2017) Anti-Neutrophil Cutoplasmic Antibody-Associated Vasculitis. In: Firestein, G.S., Budd, R.C., Gabriel, S.E., McInnes, I.B. and O’Dell, J.R., Eds., Kelley and Firestein’s Textbook of Rheumatology, Elsevier, Philadelphia, 1541-1558, Chapter 89. https://doi.org/10.1016/B978-0-323-31696-5.00089-9
|
[29]
|
Spalton, D.J., Graham, E.M., Page, N.G., et al. (1981) Ocular Changes in Limited Forms of Wegener’s Granulomatosis. British Journal of Ophthalmology, 65, 553-563. https://doi.org/10.1136/bjo.65.8.553
|
[30]
|
Fauci, A.S., Haynes, B.F., Katz, P., et al. (1983) Wegener’s Granulomatosis: Prospective Clinical and Therapeutic Experience with 85 Patients for 21 Years. Annals of Internal Medicine, 98, 76-85. https://doi.org/10.7326/0003-4819-98-1-76
|
[31]
|
Woo, T.L., Francis, I.C., Wilcsek, G.A., et al. (2001) Australasian Orbital and Adnexal Wagener’s Study Group. Australasian Orbital and Adnexal Wegener’s Granulomatosis. Ophthalmology, 108, 1535-1543. https://doi.org/10.1016/S0161-6420(01)00655-8
|
[32]
|
Tan, L.T., Davagnanam, I., Isa, H., et al. (2015) Clinical and Imaging Features of Lacrimal Gland Involvement in Granulomatosis with Polyangiitis. Ophthalmology, 122, 2125-2129. https://doi.org/10.1016/j.ophtha.2015.06.026
|
[33]
|
Ahmed, M., Niffenegger, J.H., Jakobiec, F.A., et al. (2008) Diagnosis of Limited Ophthalmic Wegener’s Granulomatosis: Distinctive Pathologic Features with ANCA Test Confirmation. International Ophthalmology, 28, 35-46. https://doi.org/10.1007/s10792-007-9109-y
|
[34]
|
Kalina, P.H., Lie, J.T., Campbell, R.J., et al. (1992) Diagnostic Value and Limitations of Orbital Biopsy in Wegener’s Granulomatosis. Ophthalmology, 99, 120-124. https://doi.org/10.1016/S0161-6420(92)32028-7
|
[35]
|
Haubitz, M., Schellong, S., Göbel, U., et al. (1998) Intravenous Pulse Administration of Cyclophosphamide versus Daily Oral Treatment in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Renal Involvement: A Prospective, Randomized Study. Arthritis & Rheumatology, 41, 1835-1844. https://doi.org/10.1002/1529-0131(199810)41:10<1835::AID-ART16>3.0.CO;2-Q
|
[36]
|
Joshi, L., Tanna, A., McAdoo, S.P., et al. (2015) Long-Term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis: Impact on Localized and Nonlocalized Disease. Ophthalmology, 122, 1262-1268. https://doi.org/10.1016/j.ophtha.2015.01.016
|
[37]
|
Bitik, B., Kılıç, L., Küçükşahin, O., et al. (2015) Retro-Orbital Granuloma Associated with Granulomatosis with Polyangiitis: A Series of Nine Cases. Rheumatology International, 35, 1083-1092. https://doi.org/10.1007/s00296-014-3179-8
|
[38]
|
Joshi, L., Lightman, S.L., Salama, A.D., et al. (2011) Rituximab in Refractory Ophthalmic Wegener’s Granulomatosis: PR3 Titers May Predict Relapse, But Repeat Treatment Can Be Effective. Ophthalmology, 118, 2498-2503. https://doi.org/10.1016/j.ophtha.2011.06.009
|
[39]
|
Baslund, B., Wiencke, A.K., Rasmussen, N., et al. (2012) Treatment of Orbital Inflammation with Rituximab in Wegener’s Granulomatosis. Clinical and Experimental Rheumatology, 30, S7-S10.
|
[40]
|
El-Shabrawi, Y. and Hermann, J. (2005) Anti-TNF Alpha Therapy in Chronic Necrotizing Scleritis Resistant to Standard Immunomodulatory Therapy in a Patient with Wegener’s Granulomatosis. Eye, 19, 1017-1018. https://doi.org/10.1038/sj.eye.6701712
|
[41]
|
Kontkanen, M., Paimela, L. and Kaarniranta, K. (2010) Regression of Necrotizing Scleritis in Wegener’s Granulomatosis after Infliximab Treatment. Acta Ophthalmologica, 88, e96-e97. https://doi.org/10.1111/j.1755-3768.2009.01546.x
|
[42]
|
Wieringa, W.G., Wieringa, J.E., ten Dam-van Loon, N.H., et al. (2013) Visual Outcome, Treatment Results, and Prognostic Factors in Patients with Scleritis. Ophthalmology, 120, 379-386. https://doi.org/10.1016/j.ophtha.2012.08.005
|